LONDON, UK / ACCESSWIRE / January 16, 2018 / Active-Investors.com has just released a free research report on Boston Scientific Corp. (NYSE: BSX). If you want access to this report all you need to do ...

Adrian-based Michigan Pain Specialists providers are using the Spectra WaveWriter Spinal Cord Stimulator System to help patients cope with chronic pain, Lenconnect.com reports. Here's what you should ...

The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...

Boston Scientific Corporation’s BSX successful result from its WHISPER randomized controlled trial (RCT) further boosts its neuromodulation business. This announcement follows the recent FDA approval ...

Boston ScientificBSX is hitting headlines with successive new developments, the latest feat being the company's Spectra WaveWriter Spinal Cord Stimulator System (SCS) getting an FDA nod. Per Boston ...

MARLBOROUGH, Mass., Jan. 11, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Spectra WaveWriter™ Spinal ...

System offers multiple non-drug therapies for people with chronic pain PARIS, Jan. 31, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra ...

LONDON, UK / ACCESSWIRE / January 16, 2018 / Active-Investors.com has just released a free research report on Boston Scientific Corp. (NYSE: BSX). If you want access to this report all you need to do ...

The Spectra WaveWriter SCS System allows physicians and patients to specifically target one area of pain, or multiple areas, with one or both types of therapy to address individual needs. Patients are ...

SCS works by sending electrical impulses to the spinal cord and masking the pain messages travelling to the brain. These electrical impulses can vary in frequency, pulse width and amplitude and ...